Related Experiment Video

Updated: Jul 9, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Expression of p16(INK4A) gene in human pituitary tumours

Gloria Machiavelli1, Javier Cotignola, Karina Danilowicz

  • 1Genética y Biología Moleclar, Universidad de Buenos Aires, Junín 956, Buenos Aires 1113, Argentina.

Pituitary
|December 7, 2007
PubMed

Insights

Pituitary adenoma development mechanisms are unclear. This study found impaired p16(INK4A) gene expression in non-functioning pituitary macroadenomas, suggesting its role in tumor progression.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Pituitary adenomas are common intracranial tumors with unknown development mechanisms.
  • The retinoblastoma pathway, crucial for cell cycle regulation, is frequently altered in tumors.
  • The cyclin-dependent kinase inhibitor p16(INK4A) is a key tumor suppressor gene.

Purpose of the Study:

  • To investigate the expression of the p16(INK4A) gene in human pituitary adenomas.
  • To determine if p16(INK4A) gene expression is associated with specific pituitary adenoma subtypes or size.

Main Methods:

  • Studied p16(INK4A) gene expression at the mRNA level using RT-PCR and electrophoresis.
  • Analyzed 46 pituitary tumor specimens, including non-functioning, growth hormone-secreting, prolactin-secreting, adrenocorticotropin-secreting, and thyrotropin-secreting adenomas.
  • Correlated p16(INK4A) expression with tumor subtype and size (macroadenomas vs. microadenomas).

Main Results:

  • p16(INK4A) mRNA was undetectable in 62% of non-functioning adenomas, significantly higher than other subtypes.
  • Impaired p16(INK4A) expression was observed in 40% of macroadenomas and 25% of microadenomas.
  • Absence of p16(INK4A) mRNA in microadenomas suggests it may be an early event in tumor development.

Conclusions:

  • Clinically non-functioning macroadenomas exhibit significantly impaired p16(INK4A) expression compared to other pituitary tumor subtypes.
  • The absence of p16(INK4A) may be an early event in the development of certain pituitary adenomas.
  • Other regulatory pathways likely contribute to the development of pituitary tumors with preserved p16(INK4A) expression.

More Related Videos

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...